Will the FDA approve any psychedelic substance for medical use this year?
2.0 puan (24s)Health & MedicineOne-Off3ay
KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel ima edilen olasılık
Hayır 74%
Piyasa kalitesi
65 / 100
Orta kalite24s Hacim
₺14,2 B
Likidite
₺4,3 Mn
Yüksek likiditeAlış / Satış
26.0% / 31.0%
Spread
5.0 pt
Orta spreadPiyasa verileri
11 dakika önce güncellendi
17 Tem 25 14:00 UTC1 Oca 27 04:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Manifold MarketsWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill the FDA approve MDMA for PTSD?
KalshiWill the FDA approve a psilocybin treatment during 2026?
FutuurWill a psychedelic substance get de-scheduled by the US by 2030?
Manifold MarketsKurallar
If the FDA approves any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes.
- Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca.
- Important information: For purposes of this Contract:
- The listed substances are illustrative, not exhaustive.
- Approval of any other substance commonly recognized in scientific or FDA documentation as a psychedelic, hallucinogen, or entactogen (for example, psilocin, 5-MeO-DMT, methylone, or 2C-, DOx-, or NBOMe-family compounds) may also satisfy the Payout Criterion.
- "Approval for medical use" means an FDA approval letter for an NDA or BLA authorizing marketing of a drug or biologic for human medical use in the United States, where a listed (or otherwise qualifying) psychedelic substance is an active pharmaceutical ingredient of the approved product.
Sık sorulan sorular
- Will the FDA approve any psychedelic substance for medical use this year? için güncel oranlar nedir?
- Kalshi, 9 Eylül 2026 itibarıyla No için 74% fiyatlıyor.
- Will the FDA approve any psychedelic substance for medical use this year? ne zaman sonuçlanacak?
- Will the FDA approve any psychedelic substance for medical use this year? için öngörülen sonuçlanma tarihi 1 Ocak 2027.
- Will the FDA approve any psychedelic substance for medical use this year? nasıl sonuçlandırılıyor?
- Kalshi bu piyasayı şu şekilde sonuçlandırır: If the FDA approves any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes.
